Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

1-methyl-3-isobutylxanthine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Roderick, JE1
Gallagher, KM1
Murphy, LC1
O'Connor, KW1
Tang, K1
Zhang, B1
Brehm, MA1
Greiner, DL1
Yu, J1
Zhu, LJ1
Green, MR1
Kelliher, MA1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
    Blood, 2021, 01-28, Volume: 137, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tum

2021